US · YDES
YD Bio Limited Ordinary Shares
- Sector
- Healthcare · Biotechnology
- Headquarters
- Taipei, TP 115001
- Website
- ydesgroup.com
Price · as of 2026-08-31
$3.78
Market cap 159.37M
Price history
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | — | — |
| P/E | -58.60 | |
| P/B | -170.56 | |
| P/S | 816.08 | |
| EV/EBITDA | -59.36 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | |||||
| 2025 | $7.30 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Growth | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| YDES | YD Bio Limited Ordinary S… | $2.30 | 159.37M | — | — | -58.60 | -170.56 | 816.08 | -59.36 | 16.94% |
| BTX | BlackRock Innovation and … | $8.52 | 994.37M | — | — | — | — | — | — | -71.78% |
| GERN | Geron Corporation | $1.63 | 1.05B | $20.93 | +1,184% | -12.28 | 4.66 | 5.73 | -18.20 | 138.83% |
| GLUE | Monte Rosa Therapeutics, … | $15.61 | 1.32B | $24.11 | +54% | -34.45 | 5.71 | 10.76 | -31.65 | 63.54% |
| LENZ | LENZ Therapeutics, Inc. | $5.27 | 165.24M | — | — | -4.26 | 1.23 | 18.34 | -0.72 | — |
| MRVI | Maravai LifeSciences Hold… | $6.41 | 930.06M | $46.68 | +628% | -3.42 | 2.10 | 2.41 | -1.80 | -28.34% |
| PRME | Prime Medicine, Inc. | $3.08 | 556.3M | $13.65 | +343% | -2.70 | 4.49 | 117.22 | -2.46 | 55.28% |
| TBPH | Theravance Biopharma Inc | $16.90 | 875.9M | $395.66 | +2,241% | 6.55 | 2.34 | 6.45 | 3.30 | 66.92% |
| TYRA | Tyra Biosciences, Inc. | $25.71 | 1.53B | — | — | -18.00 | 8.33 | — | -15.98 | — |
| VIR | Vir Biotechnology, Inc. | $9.11 | 1.54B | $11.06 | +21% | -2.93 | 1.68 | 18.71 | -2.36 | -7.61% |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $3.78) − 1 = — (IC, example).